Mineralys Therapeutics MLYS
NASDAQ MLYS
$28.21 -0.06 (-0.21%)
As of: Sep 4, 2026 · 3:59 PM EDT

Mineralys Therapeutics (MLYS) Property, Plant & Equipment (Net) (2024 - 2026)

Analysis

Mineralys Therapeutics (MLYS) Property, Plant & Equipment (Net) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Mineralys Therapeutics 2.39 Bn 2.39 Bn - 27,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27,000.00
Mar 31, 2026 32,000.00
Dec 31, 2025 38,000.00
Sep 30, 2025 7,000.00
Jun 30, 2025 22,000.00
Mar 31, 2025 38,000.00
Dec 31, 2024 53,000.00
Sep 30, 2024 69,000.00
Jun 30, 2024 42,000.00
Mar 31, 2024 51,000.00